Johnson & Johnson to acquire Abbott Medical Optics
September 17th 2016Ready for some big news? Johnson & Johnson announced they have entered into a definitive agreement to acquire Abbott Medical Optics (AMO) for $4.325 billion in cash. AMO’s business segments include cataract surgery, laser refractive surgery, and consumer eye health, and reported sales in 2015 were $1.1 billion.
Why surgeons should not undersell their femtosecond laser
September 16th 2016When it comes to their eyes, patients want the safest treatments, and they know the best technology available is a laser. The cataract patient demographic is changing, and patients today have active lifestyles that demand functional vision.
Optimizing toric IOL outcomes via techniques, technologies
September 15th 2016Achieving spectacle independence for distance vision after toric IOL implantation depends on the refractive outcome. Factors affecting residual astigmatism and studies evaluating the use of various surgical techniques and technologies relating to those factors are discussed.
Is the world a better place because of your practice?
September 15th 2016When Martin Luther King said, “I have a dream,” he had a vision for people, not a program. Visionary leaders have the ability to communicate values and ideas in a way that connects. In your practice, they bring certainty into the uncertain world of reimbursement rates and rapid change. What is your capacity to bring vision and direction into times of uncertainty?
Achieving patient satisfaction with multifocal IOLs
September 1st 2016Multifocal IOLs offer the potential to reduce spectacle dependence, but outcomes vary depending on optical design. Optimizing success and satisfaction depends on careful patient selection, thorough counseling, and good surgical technique.